Chris Bradley, CEO, Speaking at Weill Cornell Event
May 22, 2016
The Bend to Bedside Initiative, an organization based out of Weill Cornell Medicine, is hosting “Commercializing Life Science – Business Matchmaking” event to gather a diverse group of people from academic research, technology, healthcare/medicine and the business communities to address innovation in healthcare.
Weill Cornell Medicine – 1300 York Ave. 2nd Floor – Weill Auditorium C-200 New York, NY
Tuesday, May 24 at 6:30pm
During the event you’ll hear from 4 different speakers who will present and lead discussions about their respectful areas: 3D printing, big data, medical devices and clinical decision making in today’s healthcare market. You’ll meet key decision makers from Sols, Mana Health, Audicus, and Harandi Health and Longevity. These speakers will not only share their expertise in market dynamics and opportunities but will also facilitate productive team up session.
BBI builds teams around patented technologies at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Rockefeller University. It began as a graduate student club in 2010 and has resulted in the creation of several seed-funded life sciences startups. Today it unites scientists from these medical universities and professionals in NYC interested in entrepreneurship and/or venture capital in the life sciences. BBI’s mission is to provide scientists in the community with the tools needed to translate their ideas into commercial products that will benefit patients.